Ukrainian Scientists Feel Helpless at Antarctic Base as War Rages

Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
TT

Ukrainian Scientists Feel Helpless at Antarctic Base as War Rages

Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP
Ukranian scientists at the Vernadsky Antarctic base hold a national flag Oksana SAVENKO Ukrainian Antarctic Akademik Vernadsky Station/AFP

For a dozen Ukrainian scientists thousands of kilometers from home at the Vernadsky Antarctic base, the biting cold hurts less than the feeling of helplessness over the war in their homeland.

They spend their days measuring, observing, analyzing and doing their jobs as best they can as a way of coping with the situation, AFP said.

"At the beginning, we didn't sleep for a few days. The whole time we were following news about our home cities," meteorologist Anastasiia Chyhareva, 26, told AFP in messages sent from the base.

Once the invasion was in full swing, the scientists started waking at 2:00 am -- 7:00 am in Ukraine -- to check in on family and see how their night went.

"Now, we're used to it... used to checking news in the morning and before going to bed, in every free minute."

The Ukrainian base is situated on Galindez island, some 1,200 kilometers (745 miles) from Tierra del Fuego in the far south of Argentina.

It is occupied all year round by a dozen people who have to endure temperatures that drop to -20 degrees Celsius (-4 degrees Fahrenheit) in winter.

The scientists' duties include observing meteorological, geophysical, geological and biological conditions, unless the weather forces them to shelter at the base.

"My first impression was like all these things happened in another universe, not our world," said geophysicist Oleksandr Koslokov, whose family lived in war-torn Kharkiv, a heavily targeted city just 40 kilometers from the Russian border.

"I started advising my family on what to do. I had no time to reflect. I had to help my family to survive and to escape from my city... before it became a burning and unpredictable hell.

"My wife heard and felt the explosions of cruise missiles 10 minutes after (Russian President Vladimir) Putin started this stupid and criminal war."

Since then, his family has fled to Germany.

- 'Our part of the war' -
At the base, which is named after a Soviet mineralogist and geochemist with Russian and Ukrainian roots, the scientists try to live as normal a life as possible. Sunday is a day off and Saturday night everyone has dinner together before playing board games and musical instruments.

"It is hard to be so far away from my family and have no possibility to support them," said biologist Artem Dzhulai, 34.

"At the station now, there is a wide range of feelings -- from sadness due to anxiety for relatives and friends, to high spirits, due to pride in our army and the people who are bravely fighting for the right to live in a free country," said marine biologist Oksana Savenko, who is studying humpback whales.

Giving practical advice, moral support, donating to the Ukrainian army, signing a petition, creating online lectures to divert Ukrainian children's attention from the war: the scientists are trying every means available to help in some way.

"It is our part of the war" effort, said Chyhareva.

Ukrainians "try to help each other, they try to help our compatriots, they try to help our army," said another scientist who requested to remain anonymous.

- 'Don't forget us' -
Dzhulai still remains bitter over the West's response the last time Russia invaded Ukraine, annexing Crimea in 2014.

"All democratic countries were indifferent to that act of violence," he said.

"Probably, they hoped that they will not be affected by someone else's grief... but everything can change if evil is not stopped and punished.

"A lot of children in Ukraine died because of the indifference of Europe and the US."

There is fear that the same could happen again.

"Please, don't forget about us after one month, don't be tired of Ukraine and our problems," said Chyhareva.

This team will be replaced later this month, and with their homeland in flames, the departing scientists face an uncertain future.

"I don't have any real plans," said Chychareva, who just hopes to go "back to Ukraine as soon as it will be possible."

"My university in Kharkiv where I studied was destroyed ... my research institute and scientific equipment in Ukraine are destroyed," said Koslokov.

He said he would likely try to continue doing science in Europe or America, adding "time will tell."



Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
TT

Ozempic Hailed as 'Fountain of Youth' that Slows Aging

The is available under the brand names Wegovy and Ozempic (Photo by Reuters)
The is available under the brand names Wegovy and Ozempic (Photo by Reuters)

The anti-obesity drug Ozempic could slow down ageing and has “far-reaching benefits” beyond what was imagined, researchers have suggested.

Multiple studies have found semaglutide (available under the brand names Wegovy and Ozempic) reduced the risk of death in people who were obese or overweight and had cardiovascular disease without diabetes, The Independent reported.

Responding to research published in JACC, the flagship journal of the American College of Cardiology, Professor Harlan M Krumholz from the Yale School of Medicine, said: “Semaglutide, perhaps by improving cardiometabolic health, has far-reaching benefits beyond what we initially imagined.”

He added: “These ground-breaking medications are poised to revolutionise cardiovascular care and could dramatically enhance cardiovascular health.”

Multiple reports also quoted Professor Krumholz saying: “Is it a fountain of youth?”

He said: “I would say if you’re improving someone’s cardiometabolic health substantially, then you are putting them in a position to live longer and better.

“It’s not just avoiding heart attacks. These are health promoters. It wouldn’t surprise me that improving people’s health this way actually slows down the ageing process.”

The studies, presented at the European Society of Cardiology Conference 2024 in London, were produced from the Select trial which studied 17,604 people aged 45 or older who were overweight or obese and had established cardiovascular disease but not diabetes.

They received 2.4 mg of semaglutide or a placebo and were tracked for more than three years.

A total of 833 participants died during the study with 5 percent of the deaths were related to cardiovascular causes and 42 per cent from others.

Infection was the most common cause death beyond cardiovascular, but it occurred at a lower rate in the semaglutide group than the placebo group.

People using the weight-loss drug were just as likely to catch Covid-19, but they were less likely to die from it – 2.6 percent dying among those on semaglutide versus 3.1 per cent on the placebo.

Researchers found women experienced fewer major adverse cardiovascular events, but semaglutide “consistently reduced the risk” of adverse cardiovascular outcomes regardless of sex.

Dr Benjamin Scirica, lead author of one of the studies and a professor of cardiovascular medicine at Harvard Medical School, said: “The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising and perhaps only detectable because of the Covid-19-related surge in non-cardiovascular deaths.

“These findings reinforce that overweight and obesity increases the risk of death due to many etiologies, which can be modified with potent incretin-based therapies like semaglutide.”

Dr Jeremy Samuel Faust, an emergency medicine physician at Brigham and Women’s Hospital, praised the researchers for adapting the study to look at Covid-19 when the pandemic started.

He said the findings that the weight-loss drug to reduce Covid-19 mortality rates were “akin to a vaccine against the indirect effects of a pathogen.”